Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projected to experience steady earnings growth, with anticipated GAAP earnings increasing to $4.73 per diluted share for full-year 2025 and $5.17 per diluted share for 2026, reflecting a positive outlook driven by the strength of its Human Nutrition and Health segment. The company reported 2Q25 top-line revenue of $255.5 million, which surpassed estimates and marked a 1% year-over-year increase, along with slight sequential growth from the previous quarter. Additionally, improvements in gross and net margins are expected, complemented by a potential debt-free status by the end of next year, positioning Balchem favorably for future strategic acquisitions given its strong balance sheet.

Bears say

Balchem Corp has experienced declining performance metrics, with the P/E multiple decreasing to 37.9x from 39.6x, suggesting diminished investor confidence. The company has exhibited slower-than-anticipated growth in its core segments, with missed revenue targets for both the Animal Nutrition and Health segment, which reported sales of $56.4 million compared to an estimate of $60 million, and the Specialty Products segment, which generated $1.4 million against an expected $1.6 million. Additionally, various risks, including inflationary pressures, difficulties in product launches, and potential disruptions in European operations, further exacerbate the negative outlook for Balchem's stock.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.